ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CBMG Cellular Biomedicine Group Inc

19.74
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cellular Biomedicine Group Inc NASDAQ:CBMG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 19.74 19.74 19.80 0 01:00:00

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action...

23/04/2015 7:01pm

GlobeNewswire Inc.


Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Cellular Biomedicine Charts.

The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Cellular Biomedicine Group Inc. (Nasdaq:CBMG) between June 18, 2014 and April 7, 2015.         

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. If you purchased or otherwise acquired Cellular Biomedicine Group Inc. ("Cellular Biomedicine") securities between June 18, 2014 and April 7, 2015, your rights may be affected by this action. To get more information go to:

HTTP://ZLKDOCS.COM/CBMG-INFO-REQUEST-FORM-2850

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that, among other allegations, the Company used paid stock promoters to achieve its $500 million valuation, but failed to disclose the use of promoters in its regulatory filings.

On April 7, 2015, an article featured on Seeking Alpha alleged that the Company was engaged in a fraudulent scheme to mislead investors.

If you suffered a loss in Cellular Biomedicine you have until June 22, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free: (877) 363-5972
         Fax: (866) 367-6510
         www.zlk.com

1 Year Cellular Biomedicine Chart

1 Year Cellular Biomedicine Chart

1 Month Cellular Biomedicine Chart

1 Month Cellular Biomedicine Chart

Your Recent History

Delayed Upgrade Clock